EVERSANA is proud to be a Global Sponsor at this year’s Orphan Drugs & Rare Diseases Congress series to provide a comprehensive overview of the critical issues shaping the future of 0rphan drugs.
We are on a mission to advance the drug development and commercialization of orphan drugs. Together with our clients, we aim to create better patient experiences and bring effective therapies to patients around the world.
12th Orphan Drugs & Rare Diseases Global Congress 2020 Europe
October 20-21, 2020
London, UK | Virtual
Join EVERSANA’s Oodaye Shukla, Chief Data and Analytics Officer, on October 20 at 12 PM BST as Plenary Keynote Speaker:
Leveraging AI to Advance Rare Disease Patient Identification & Commercialization
- How to build an AI-compatible data ecosystem that incorporates healthcare and non-healthcare data sources
- How to extract actionable insights, such as identifying undiagnosed patients, from data through AI
- What constitutes an AI-driven insight, and how to translate these insights to drive the next best action for commercial activities
13th Orphan Drugs & Rare Diseases Global Congress 2020 Americas – East Coast
November 17-19, 2020
Boston, MA, US | Virtual
More information to come!
Talk with our business experts to learn more about how we are advancing the drug development and commercialization of orphan drugs. Click the button below to schedule a meeting.
Read Oodaye Shukla’s recent white paper: “The Evolving World of Artificial Intelligence: Rare Disease Impact”
To learn more about our Data & Analytics solutions visit: ACTICS by EVERSANATM